Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today provided an update on the status of its research and development programs at the Piper Jaffray 25th Annual Healthcare Conference in New York.
Help employers find you! Check out all the jobs and post your resume.
